Related Experiment Video
Updated: Aug 6, 2026

Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells
Published on: December 13, 2016
Binding of monovalent anions to human serum transferrin
W R Harris1, A M Cafferty, S Abdollahi
1Department of Chemistry, University of Missouri-St. Louis 63121, USA. wharris@umsl.edu
Abstract:
Serum transferrin is the protein whose primary function is to bind iron and transport it through the blood. Apotransferrin has two specific metal-binding sites that bind a variety of metal ions in addition to the ferric ion. The distinguishing feature of the transferrins is that a "synergistic" bicarbonate anion is bound along with the metal ion to form a stable Fe(3+)-CO3-Tf ternary complex. Previous research has shown that apotransferrin will also bind divalent anions such as phosphate and sulfate. Difference UV spectroscopy has now been used to show that a series of monovalent anions bind weakly to apotransferrin. Equilibrium constants for the binding of chloride, perchlorate, bromide, fluoride and Hepes have been calculated. A reaction scheme for the binding of anions is proposed which predicts that the binding of the nonsynergistic anions to apotransferrin will interfere with metal binding by competing directly with the binding of the synergistic bicarbonate anion. Difference UV data are presented which demonstrate this type of competition between nonsynergistic anions and Tb3+. Competition from the nonsynergistic anions follows the order HPO4(2-) > SO4(2-) approximately F- > ClO4- approximately Cl- approximately Br-. Speciation calculations have been performed to determine the concentrations of anion-apotransferrin complexes in Hepes and Tris buffers and in human serum and to estimate the extent to which competition from anions in the buffer will interfere with metal-binding to apotransferrin.
More Related Videos
Related Concept Videos
Ionic Bonding and Electron Transfer
The Early Endosome: Endocytosis of Transferrin
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Drug Distribution: Plasma Protein Binding
EDTA: Chemistry and Properties
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...

